Antithrombotics in pulmonary hypertension: more work needed before we turn to newer agents!
Eur Respir J
.
2013 Apr;41(4):775-7.
doi: 10.1183/09031936.00180512.
Authors
Laurent Bertoletti
,
Xavier Delavenne
,
David Montani
PMID:
23543644
DOI:
10.1183/09031936.00180512
No abstract available
Publication types
Editorial
Comment
MeSH terms
Anticoagulants / adverse effects*
Female
Hemorrhage / chemically induced*
Humans
Hypertension, Pulmonary / drug therapy*
Male
Vitamin K / antagonists & inhibitors*
Substances
Anticoagulants
Vitamin K